Appointments
Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two newly-created roles: Dr...
Paolo Chiesi, Vice President of the Chiesi Group, has been made an Honorary Doctor at the Karolinska Institutet – a research led medical...
Mundipharma has announced that Jerome Moreau has joined the company as its new Head of Market Access.
Moreau has amassed experience in a...
MedImmune’s Vice President of Clincial Development Oncology, Mohammed Dar has joined British biotech Immunocore as the company’s new CMO.
...
The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume the...
Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, has stepped...
Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor would be...
Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO.
The opioid drugmaker said the decision...
Dr Monika Lessl has been appointed to Bayer Foundations’ executive committee, selected by the German pharmaceutical firm’s Board of Management to...
Daiichi Sankyo have said Sunao Manabe, the company’s current COO will take over from George Nakayama as the firm’s new Chief Executive Officer (...